Drug Type Autologous CAR-T |
Synonyms Anti-CD171-CAR-T-cell-therapy-Juno-Therapeutics, Anti-CD171-chimeric-antigen-receptor-T-cell-therapy-Juno-Therapeutics, Anti-CD171-huma + [3] |
Target |
Mechanism L1CAM antagonists(L1 cell adhesion molecule antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroblastoma | Phase 1 | - | - | |
Neuroblastoma | Phase 1 | - | - |